Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.37 (
CNPase
)
539
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In traumatic brain injury,
absent in melanoma 2
(
AIM2
) has been demonstrated to be involved in pyroptotic neuronal cell death. Although the pathophysiological mechanism of spinal cord injury is similar to that of brain injury, the expression and cellular localization of
AIM2
after spinal cord injury is still not very clear. In the present study, we used a rat model of T9 spinal cord contusive injury, produced using the weight drop method. The rats were randomly divided into 1-hour, 6-hour, 1-day, 3-day and 6-day (post-injury time points) groups. Sham-operated rats only received laminectomy at T9 without contusive injury. Western blot assay revealed that the expression levels of
AIM2
were not significantly different among the 1-hour, 6-hour and 1-day groups. The expression levels of
AIM2
were markedly higher in the 1-hour, 6-hour and 1-day groups compared with the sham, 3-day and 7-day groups. Double immunofluorescence staining demonstrated that
AIM2
was expressed by NeuN
+
(neurons), GFAP
+
(astrocytes),
CNPase
+
(oligodendrocytes) and CD11b
+
(microglia) cells in the sham-operated spinal cord. In rats with spinal cord injury,
AIM2
was also found in CD45
+
(leukocytes) and CD68
+
(activated microglia/macrophages) cells in the spinal cord at all time points. These findings indicate that
AIM2
is mainly expressed in neurons, astrocytes, microglia and oligodendrocytes in the normal spinal cord, and that after spinal cord injury, its expression increases because of the infiltration of leukocytes and the activation of astrocytes and microglia/macrophages.
...
PMID:Expression and localization of absent in melanoma 2 in the injured spinal cord. 3053 25